News | January 29, 2008

Intravascular MRI System Used in Vulnerable Plaque Study

January 30, 2008 - TopSpin Medical Inc. installed the Cathamaran Intravascular MRI System at ZOL Hospital in Belgium, marking the first installation of the system and its entrance in a study on vulnerable plaque.

The Cathamaran IVMRI System, designed for both diagnostic and interventional coronary catheterization procedures, will enable the clinicians at TopSpin to detect and quantify lipid present in coronary lesions. The Cathamaran IVMRI System will be used in a postmarket Study of coronary plaque lipid characterization by IVMRI performed during diagnostic or interventional catheterization [MIRACLE Study]. The multinational prospective MIRACLE Study is designed to collect data to evaluate how lipid quantification with the IVMRI System may be used to guide patient treatment.

“We are very excited to be among the first centers to participate in the MIRACLE Study to further evaluate the clinical role for IVMRI in both diagnostic and interventional coronary catheterization procedures. The identification of high risk, lipid -rich lesions that may be prone to rupture is of paramount importance, and the IVMRI System may potentially help address this unmet need," stated M. Vrolix, M.D., from ZOL hospital, Belgium.

For more information: www.Topspin.co.il

Related Content

Circle Cardiovascular Imaging and Galgo Medical Enter Distribution and Joint Development Agreement
News | Magnetic Resonance Imaging (MRI) | February 14, 2019
Circle Cardiovascular Imaging and Galgo Medical recently announced an agreement for distribution and joint development...
FDA Clears Magnetom Lumina 3T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | January 30, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic resonance imaging (...
HeartVista Announces One Click Autonomous MRI Solution
News | Magnetic Resonance Imaging (MRI) | November 25, 2018
HeartVista announced its artificial intelligence (AI)-driven, One-Click Autonomous MRI acquisition software for cardiac...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
Stress Cardiac MRI Shows High Prognostic Value for Suspected Ischemia Patients
News | Magnetic Resonance Imaging (MRI) | September 17, 2018
Raymond Kwong, M.D., MPH, from the Harvard Medical School recently presented his findings on a study of how single-...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

Feature | Magnetic Resonance Imaging (MRI) | February 28, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Overlay Init